Norwegian SCAD follow-up and outcomes program

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

NOR-SCAD is a multicenter prospective observational cohort enrolling adults hospitalized with angiographically or imaging-confirmed spontaneous coronary artery dissection at major Norwegian hospitals from 2025–2035. Participants are followed for 52 weeks with planned in-person visits at about 8 and 12 weeks and a final phone call at 52 weeks. Evaluations include coronary CT angiography (CTA), cardiac exams, cardiopulmonary exercise testing (CPET), genetic analyses, blood sampling, and structured questionnaires. Primary endpoints are incidence and types of complications and major adverse cardiac events (MACE), with a secondary focus on the diagnostic and follow-up utility of coronary CTA.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Spontaneous coronary artery dissection

Exclusion Criteria:

* Severe kidney failure
* Severe allergic reaction to contrast

Where it's running

• Haukeland University Hospital
  Bergen, Norway Recruiting
• Akershus University Hospital
  Oslo, Norway Recruiting
• Rikshospitalet, Oslo University Hospital
  Oslo, Norway Recruiting

Study contacts

• Principal investigator: Mette Elise Estensen, MD., PhD — ProCardio, Kardiologisk avdeling Rikshospitalet, Oslo Univeristy Hospital
• Study coordinator: Anna Louise Astad Sørlie, MD
• Email: anloso@ous-hf.no
• Phone: +47 926 55 483

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Risk of malignant arrhythmias after acute coronary syndrome

  This study tracks how often dangerous heart rhythms occur in adults admitted for ACS and looks for patterns that might predict them.

  Recruiting Catharina Ziekenhuis Eindhoven · Eindhoven, North Brabant · NCT07824050

• Smartphone AI help for prehospital ECG readings

  This study tests whether using a smartphone AI (GPT-4o) to help prehospital providers read 12-lead ECGs improves accuracy in diagnosing acute coronary syndromes and related conditions.

  Recruiting École Supérieure de Soins Ambulanciers - College of Higher Education in Prehospital Care · Murten/Morat, Canton of Fribourg · NCT07810686

• Optimal timing of staged complete revascularization in STEMI with multivessel disease

  This trial tests whether performing staged complete revascularization during the hospital stay or after discharge is best for STEMI patients with multivessel disease.

  Recruiting Chonnam National University Hospital · Bucheon-si and 29 other locations · NCT07741721

• BEAT-SHOCK: Baseline Registry for Acute Cardiogenic Shock at Basel

  This registry collects and shares data on adults with cardiogenic shock admitted to University Hospital Basel to help understand how these patients are treated and how they fare.

  Recruiting University Hospital, Basel, Switzerland · Basel, Canton of Basel-City · NCT07643610

• Low-dose IL-2 after heart attack to study tissue-resident regulatory T cells

  Researchers are testing whether low-dose interleukin-2 given after a myocardial infarction can boost tissue-resident regulatory T cells to support heart repair.

  Recruiting at 2 sites Cambridge University Hospitals NHS Foundation Trust · Cambridge, Cambridgeshire and 1 other locations · NCT07610538

• Abbreviated antithrombotic therapy after PCI in AF and MI

  This trial tests whether DOAC-only therapy works as well as DOAC plus clopidogrel after PCI in people with atrial fibrillation and a recent heart attack.

  Recruiting Chonnam National University Hospital · Gwangju, Gwangju · NCT07583784

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.